245.1 Alterations in the ileal effluent microbiota predict acute rejection in intestinal transplant recipients
Dr. Guosheng Wu, People's Republic of China
245.3 Sirolimus treatment increases graft survival in pediatric intestinal transplant patients and is associated with a more naïve/less activated immune phenotype, and a higher frequency of regulatry T-cells
Dr. Rodrigo Papa-Gobbi, Argentina
245.5 Enteric complications and their management in intestinal transplantation over the last decade in a single large adult centre
Mr. Subhankar Paul, United Kingdom
245.6 Bleeding and thrombosis in intestinal and multivisceral transplantation - Experience from 145 consecutive cases
Dr. Francesca Reeder, United Kingdom
245.7 Outcomes of intestinal transplant in a single large adult centre
Mr. Bala Mahesh Polamreddy, United Kingdom
245.8 Shiraz Transplant Center; leader of the intestinal transplant in the Middle East; challenges and opportunities
Dr. Hamed Nikoupour, Iran
245.9 Adult Intestinal Transplant Program at King Faisal Specialist Hospital and Research Center, Riyadh, KSA